BNG-15246-88158
2 vaccinations
3 coded responses
11 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 717 / AR
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Registered in v-safe
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain, Photophobia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Photophobia and eye painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-14
-
2021-02-19
Survey response — day 42, dose 2MedDRA: Erythema, Hypoaesthesia, Paraesthesia, Temperature intolerance — Feeling: GoodFree text: Im wondering if increased cold sensitivity in digits for the last couple of months which is new this year, including reversible redness and numbness/tingling lasting up to an hour is at all related to vaccine. There is no blanching or Reynauds. ANMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-07-09
-
2022-01-08
Survey response — 12 months, dose 2MedDRA: Exposure to SARS-CoV-2, Fatigue, Headache, Nasal congestion, Nasal oedema, Neck pain, Odynophagia, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative, Upper-airway cough syndrome — Feeling: GoodFree text: October: sore throat/neck and painful swallow, post nasal drainage and swelling, COVID test (-) New Years after exposure: AM frontal headache, severe nasal congestion, mild drainage, mild fatigue No test done after improved over 3-4 daysMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Photophobia and eye pain
Release 4 — day 42, dose 2
Symptoms: Im wondering if increased cold sensitivity in digits for the last couple of months which is new this year, including reversible redness and numbness/tingling lasting up to an hour is at all related to vaccine. There is no blanching or Reynauds. AN
Release 10 — 12 months, dose 2
Symptoms: October: sore throat/neck and painful swallow, post nasal drainage and swelling, COVID test (-) New Years after exposure: AM frontal headache, severe nasal congestion, mild drainage, mild fatigue No test done after improved over 3-4 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyperaesthesia | ○ | ○ | ○ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasal oedema | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Odynophagia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Temperature intolerance | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release